About

About Reliant Glycosciences Reliant Glycosciences, LLC is a biotechnology company dedicated to developing diagnostic and prognostic tools for patients with IgA nephropathy (IgAN). The company's objective is to create marketable assays for IgAN-specific biomarkers, making them accessible to both the IgAN research community and pharmaceutical companies interested in developing treatments for this condition. Reliant offers its own GalD Assay, which measures the level of galactose-deficient IgA1 (Gd-IgA1) in human serum samples. This assay is quantitatively assessed using a lectin-based ELISA test. Reliant aims to make a meaningful impact on the disease and its treatment.